Epitalon

Anti-Aging

Epithalon — Synthetic Peptide

Amino Acid SequenceAla-Glu-Asp-Gly
3
Studies
4
Amino Acids
390.35
Mol. Weight
2
Routes

Overview

Epitalon (also spelled Epithalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology in Russia. It is the synthetic analogue of Epithalamin, a peptide extract derived from the bovine pineal gland that was studied for its anti-aging properties beginning in the 1980s. Epitalon was designed to reproduce the biological activity of Epithalamin in a defined, reproducible synthetic form.

The primary research interest in Epitalon centers on its reported ability to activate telomerase, the enzyme responsible for maintaining telomere length at chromosome ends. Telomere shortening is a hallmark of cellular aging, and interventions that preserve telomere length have been hypothesized to extend cellular and organismal lifespan. While Epitalon research has generated intriguing in vitro and animal data, the evidence base consists primarily of studies from a single research group, and no large-scale clinical trials have been conducted outside of Russia.

Mechanism of Action

Epitalon's proposed primary mechanism involves activation of telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase. In vitro studies have shown that exposure to Epitalon increases telomerase activity in human somatic cells, enabling additional cell divisions beyond the Hayflick limit and elongating telomeres that had shortened with successive divisions. The specific molecular pathway by which a tetrapeptide activates hTERT transcription has not been fully elucidated, though it may involve epigenetic modifications to the hTERT promoter region.

A secondary mechanism involves chromatin remodeling. Epitalon has been shown to induce decondensation of heterochromatin in aged lymphocytes, reactivating ribosomal genes that become silenced with age. This effect on chromatin architecture may be functionally related to its telomerase activation, as both processes involve reversal of age-associated epigenetic changes. The peptide may also influence melatonin secretion patterns, given its origin as a pineal-derived compound, though this relationship is less well-characterized for the synthetic tetrapeptide versus the natural extract.

Research Dosing

Subcutaneous
5-10mg

Courses typically repeated every 4-6 months. Originally studied by Khavinson at St. Petersburg Institute of Bioregulation and Gerontology. No standardized clinical dosing protocol exists.

Once daily·10-20 days per course
Intravenous
10mg

IV route used in some early Russian clinical studies of Epithalamin (the pineal extract precursor). Less common than subcutaneous administration in current research.

Once daily·10 days

Research data only. These dosing ranges are derived from published studies, primarily in animal models. This is not medical advice. No peptide discussed on this site is approved for human therapeutic use unless otherwise noted.

Published Studies